UK markets close in 7 hours 25 minutes

Crescita Therapeutics Inc. (CRRTF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
0.3200-0.0005 (-0.16%)
At close: 02:14PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
627
-1,986
862
-1,105
37
-
Depreciation & amortisation
1,441
1,506
1,471
1,379
1,491
-
Deferred income taxes
290
456
-458
96
483
-
Stock-based compensation
296
82
221
272
155
-
Change in working capital
-1,227
1,606
-3,715
-2,745
1,582
-
Accounts receivable
-2,611
3,305
-2,572
-1,042
1,246
-
Inventory
-680
-917
-1,780
-1,375
-41
-
Other working capital
288
1,943
-1,249
-1,943
5,549
-
Other non-cash items
-1,129
-32
-103
74
-426
-
Net cash provided by operating activities
726
2,076
-1,020
-1,597
5,608
-
Cash flows from investing activities
Investments in property, plant and equipment
-438
-133
-229
-346
-59
-
Acquisitions, net
-
0
-61
0
-
-
Other investing activities
-
-
-
-500
-
-
Net cash used for investing activities
-438
-133
-290
-846
-59
-
Cash flows from financing activities
Debt repayment
-1,363
-408
-1,373
-349
-358
-
Common stock issued
0
-
-
-
-
0
Common stock repurchased
-412
-393
-429
-101
-68
-
Other financing activities
-
-
-50
-50
-50
-250
Net cash used provided by (used for) financing activities
-1,819
-782
-1,846
-500
-476
-
Net change in cash
-1,498
1,147
-3,093
-2,950
5,013
-
Cash at beginning of period
12,236
8,238
11,331
14,281
9,268
-
Cash at end of period
10,705
9,385
8,238
11,331
14,281
-
Free cash flow
Operating cash flow
726
2,076
-1,020
-1,597
5,608
-
Capital expenditure
-438
-133
-229
-346
-59
-
Free cash flow
288
1,943
-1,249
-1,943
5,549
-